These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12909130)

  • 21. Somatic mutations to arginine residues affect the binding of human monoclonal antibodies to DNA, histones, SmD and Ro antigen.
    Haley J; Mason LJ; Nagl S; Giles I; Latchman DS; Isenberg DA; Rahman A
    Mol Immunol; 2004 Jan; 40(11):745-58. PubMed ID: 14687932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and expression of the Fabs of human autoantibodies in Escherichia coli. Determination of the heavy or light chain contribution to the anti-DNA/-cardiolipin activity of the Fab.
    Kumar S; Kalsi J; Ravirajan CT; Rahman A; Athwal D; Latchman DS; Isenberg DA; Pearl LH
    J Biol Chem; 2000 Nov; 275(45):35129-36. PubMed ID: 10893224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y; Stollar BD
    J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.
    Gharavi AE; Sammaritano LR; Wen J; Miyawaki N; Morse JH; Zarrabi MH; Lockshin MD
    J Rheumatol; 1994 Jan; 21(1):94-9. PubMed ID: 8151598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies.
    Chukwuocha RU; Zhu M; Cho CS; Visvanathan S; Hwang KK; Rahman A; Chen PP
    Mol Immunol; 2002 Oct; 39(5-6):299-311. PubMed ID: 12220888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of heavy and light chain sequences of conventional camelid antibodies from Camelus dromedarius and Camelus bactrianus species.
    Griffin LM; Snowden JR; Lawson AD; Wernery U; Kinne J; Baker TS
    J Immunol Methods; 2014 Mar; 405():35-46. PubMed ID: 24444705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity.
    Celli CM; Gharavi AE; Chaimovich H
    Biochim Biophys Acta; 1999 Jan; 1416(1-2):225-38. PubMed ID: 9889373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies.
    Pericleous C; Miles J; Esposito D; Garza-Garcia A; Driscoll PC; Lambrianides A; Latchman D; Isenberg D; Rahman A; Ioannou Y; Giles I
    Mol Immunol; 2011 Oct; 49(1-2):56-63. PubMed ID: 21899894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.
    Sapparapu G; Planque SA; Nishiyama Y; Foung SK; Paul S
    J Biol Chem; 2009 Sep; 284(36):24622-33. PubMed ID: 19542217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.
    Ioannou Y; Pericleous C; Giles I; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2007 Jan; 56(1):280-90. PubMed ID: 17195232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine-specific antibodies: a model for T15-idiotype dominance.
    Kenny JJ; Moratz CM; Guelde G; O'Connell CD; George J; Dell C; Penner SJ; Weber JS; Berry J; Claflin JL
    J Exp Med; 1992 Dec; 176(6):1637-43. PubMed ID: 1460422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-cardiolipin/beta-2 glycoprotein activities co-exist on human anti-DNA antibody light chains.
    Kumar S; Nagl S; Kalsi JK; Ravirajan CT; Athwal D; Latchman DS; Pearl LH; Isenberg DA
    Mol Immunol; 2003 Dec; 40(8):517-30. PubMed ID: 14563371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative sequence and immunochemical analyses of murine monoclonal anti-morphine antibodies.
    Miller A; Glasel JA
    J Mol Biol; 1989 Oct; 209(4):763-78. PubMed ID: 2555519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibodies differ in aPL cofactor requirement.
    Sammaritano LR; Lockshin MD; Gharavi AE
    Lupus; 1992 Feb; 1(2):83-90. PubMed ID: 1301968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid interactions with human antiphospholipid antibody, beta 2-glycoprotein 1, and normal human IgG using the fluorescent probes NBD-PE and DPH.
    Tang D; Borchman D; Harris N; Pierangeli S
    Biochim Biophys Acta; 1998 Jun; 1372(1):45-54. PubMed ID: 9651477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-2-glycoprotein specificity of human anti-phospholipid antibody resides on the light chain: a novel mechanism for acquisition of cross-reactivity by an autoantibody.
    Kumar S; Nagl S; Kalsi JK; Ravirajan CT; Athwal D; Latchman DS; Pearl LH; Isenberg DA
    Mol Immunol; 2005 Jan; 42(1):39-48. PubMed ID: 15488942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
    Polymenis M; Stollar BD
    J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.